Facible BioDiagnostics, Inc. — Regulation A 1-A/A
Facible BioDiagnostics, Inc. of MERIDIAN, ID filed a Regulation A 1-A/A with the SEC on 2022-07-21. Aggregate offering: $40.0M (Tier 2). Industry: Other.
Offering
- Filed: 2022-07-21
- Form: 1-A/A
- Accession: 0001910594-22-000009
- Tier: Tier 2
- Total aggregate offering: $40.0M
- Issuer portion: $36.7M
- Selling securityholders: $3.3M
- Price per security: $5.8000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Assurance Dimensions
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001910594
- Organized in: DE
- Incorporated: 2022
- Address: 366 SW 5TH AVE, STE. 104, MERIDIAN, ID, 83642
- Phone: 2087576996
- Employees: 8 full-time, 2 part-time
Financial snapshot (as filed)
- Total assets: $1.4M
- Cash & equivalents: $449K
- Total liabilities: $9.1M
- Stockholder equity: $-7.6M
- Net income: $-6.4M
People (1)
| Name | Role | Location |
|---|
| Nicholas Antaki | Signer | SCOTTSDALE, AZ |
Other Reg A filings by this issuer (4)
More